Funding Rounds
Thioredoxin Systems Series A Round, October 2024
Thioredoxin SystemsDeveloper of a first-in-class antibiotic for multidrug-resistant urinary tract infections
Summary
Stage: Series A
Raised Amount: $2.40M
Raised Date: 2024-10-30
Stage: Series A
Raised Amount: $2.40M
Raised Date: 2024-10-30